<!doctype html>
<html lang="en">

<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <link
    crossorigin="anonymous"
    href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/css/bootstrap.min.css"
    integrity="sha512-GQGU0fMMi238uA+a/bdWJfpUGKUkBdgfFdgBm72SUQ6BeyWjoY/ton0tEjH+OSH9iP4Dfh+7HM0I9f5eR0L/4w=="
    referrerpolicy="no-referrer"
    rel="stylesheet"
  />
  <link rel="stylesheet" href="./static/css/oxford.css">
  <link rel="stylesheet" href="./static/css/outliers.css">

  <title>Static outliers for Dewsbury & Thornhill PCN</title>
</head>
<body>
    <div class="bg-dark">
      <div class="container d-flex justify-content-center">
        <a class="visually-hidden-focusable text-white p-2" href="#content">Skip to main content</a>
      </div>
    </div>

    <header>
      <nav class="navbar navbar-expand-lg navbar-dark bg-dark bg-oxford">
        <div class="container">
          <a class="navbar-brand" href="../index.html">OpenPrescribing outlier detection</a>
        </div>
      </nav>
    </header>

    <main id="content">
      <div class="bg-oxford-50 mb-4">
        <div class="container pt-5 pb-4">
          <div class="row">
            <div class="col-12">
              <h1 class="display-5 fw-bold lh-1">Static outliers for Dewsbury & Thornhill PCN</h1>
            </div>
            <div class="col-lg-8 col-md-9 col-12 pt-4 fs-5">
              <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
                explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
                prescribers and organisations to audit and review prescribing.</p>
              <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
                  in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
                  mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
                  population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
              </p>
              <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
                  it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
              </p>
              <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=pcn+U66858">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
                  send short or detailed feedback.
              </p>
            </div>
          </div>
        </div>
      </div>
    </main>

    <section aria-labelledby="higherHeading">
      <div class="container">
        <h2 class="pb-3" id="higherHeading">Prescribing where Dewsbury & Thornhill PCN is higher than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0407041F0&amp;denomIds=4.7.4&amp;selectedTab=summary">Ergotamine tartrate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>3</td>
      <td>Treatment of acute migraine</td>
      <td>498</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>45.43</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_8WpLuODC1m28MYR4ocQLCEExMXwNamI0"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_8WpLuODC1m28MYR4ocQLCEExMXwNamI0" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAJuElEQVR4nO3dXaxsZ1kH8P97zmmpHEI/tSVAO4qhQCWUr6CiCJho7BYDCUGIMcoFemMk8WpLuODC1m28MYR4ocQLCEExMXwNamI0EjAqH20PLSCc6ratcKAUDJEIte3iYtax050D5207a971dn6/ZGWtmVlr8rzPntnzP+9ac3YZhiEAAOdzrHUBAEAfhAYAoIrQAABUERoAgCpCAwBQRWgAAKoIDQBAFaEBAKgiNAAAVYQGAKCK0AAAVBEaAIAqQgMAUEVoAACqCA0AQBWhAQCoIjQAAFWEBgCgitAAAFQRGgCAKkIDAFBFaAAAqggNAPD9lHIypQzjcrJ1OS0JDQBAFaEBAKgiNAAAVWYbGhb7y4ta1wAAPGS2oSHJi1sXAAA8ZM6h4adaFwAAPERoAACqzDk0vHSxv5xzfQCwU+b8oXxxkutaFwEArMw5NCROUQDAbAgNAECVOYeGIUIDAMzGnEPDqSRXL/aXV7cuBACYd2j42Lh+adMqAIAkfYQGpygAYAaEBgCgymxDw+HB3t1JDpM8d7G/vKRxOQCw82YbGkafSFKS/FjrQgBg1809NHxpXF/ZtAoAYPah4cy4vqppFQCA0AAA1Jl7aPjKuHZ6AgAam3toMNMAADPRS2gw0wAAjc09NNyT1R+uMtMAAI3NOjQcHuzdn+RrSa5a7C9L63oAYJfNOjSMziS5MMnFrQsBgF3WQ2g4+w0KpygAoKEeQoNvUADADPQQGvxfDQAwAz2EBjMNADADQgMAUKWH0OD0BADMQA+hwUwDAMxAT6HBTAMANNRDaLg3yQMx0wAATc0+NBwe7D2Y5KtJrlzsL2dfLwA8XvXyIXwmyfEkl7UuBAB2VS+hwX8lDQCN9RIafIMCABrrLTT4BgUANNJLaHB6AgAa6yU0mGkAgMZ6Cw1mGgCgkV5Cg9MTANBYL6HB6QkAaKyX0PDfSe6LmQYAaKaL0HB4sDdkdYriBxf7yxOt6wGAXdRFaBidSVKSXNG6EADYRT2FBhdDAkBDPYUGX7sEgIZ6DA2+QQEADfQUGpyeAICGegoNZhoAoKEeQ4OZBgBooKfQcPe4/uGmVQDAjuopNNyZ5JtJnrvYXx5vXQwA7JpuQsPhwd6DSU4lOZnkGY3LAYCd001oGN0yrp/XtAoA2EG9hYZbx/X1TasAgB3UW2gw0wAAjfQWGm5P8mDMNADA1nUVGg4P9v43yeeTPHWxv/TXLgFgi7oKDaOz1zU4RQEAW9RjaHBdAwA00GNo8A0KAGigx9BgpgEAGuguNBwe7H0lqz+T/ZzF/vIJresBgF3RXWgY3ZLkRJJnty4EAHZFr6HBdQ0AsGW9hgbXNQDAlvUaGsw0AMCW9RoavpDk20met9hfltbFAMAu6DI0HB7s3Z/ktiSXJvnRxuUAwE7oMjSM/m5cv3exv3xS00oAYAf0HBreluSjSV6Y5C8W+8sTbcsBgMe3bkPD4cHed5K8OsnnktyQ5I9d3wAA0ynDMLSu4TFZ7C+vSfLPSa4a1/+R5EySe8ddjiUp4/K9to+Gjcd6e91wjuV4kgvWlguP3D67HE/yf0nuS/KdcX10++ztByccw7nGNJf7e66FzfEPhs3RyyOu+NY3LvzkO371piR50W+9+y1fO3npfZWHnj482PvAhKVtXfdT+ocHe/+52F/ekORvk/z4uADARnzrgh9Y377pERz6/iSPq9Awy5mGUsrtSTIMw3Wta5kTfTk3fTk3fTk3fTk3ffne9OYh3V7TAABsl9AAAFQRGgCAKkIDAFBFaAAAqggNAECVWX7lEgCYHzMNAEAVoQEAqCI0AABVhAYAoIrQAABUERoAgCpbCQ2llJeXUm4vpZwupbyzlHL8HPu8rpTyhVLKHaWUG9fuf3Ip5UOllC+WUj5ZSnn2+Y7pxYR9eV8p5Z5SyultjWWTpuhLKeX6UsrHx+e9rZTy29sc0yZM1JeTpZR/LaXcMj73n5RSTmxzXI/VVO+jtX2WPb6XJvz9Moyvl7PL5dsa0yZM2JcrSykfKKV8vpTyb6WUX9zWmLZqGIZJl6yCyekkzxlvvy/Jrx3Z5+IkdyZ5SpITSf4pyc+Mj/1ekpvG7RuS/MP5julhmaov4+1XJnlBktOtxzmXviR5ZpJrx+0nJ/likutbj3cGfTmW5Elr23+V5Ndbj7d1X9aO/ZUk7+7tvTTx75f7W49vpn35mySvG7dPJLm89Xgn6eEWfkgvSfLRtds/n+SDR/b55STvWrv9m0nePm5/LsmPrD32X0ku/37H9LBM1Ze124veftFtoy9r938wyataj3dOfUlyYZLl0V+ic16m7EuSK8YPjGf19l6auC89h4apPo+uTXJz6/FtY9nG6YmnJblr7fadSZ7+CPY5+tjd4301zztnU/Wld5P3pZTyjCQvSvLxDdS7LZP2pZTyL0nuSfLNJO/ZTMlbMWVf/ijJW5N8e1PFbtGUfTlWSvlEKeVTpZTf2VzJWzFVX56V5KullPeWUm4upbyrlHLZRiufiW2EhrKhfTZxzJxM1ZfeTdqXUsolSd6f5M3DMHz90T5PA5P2ZRiGlyR5apLLkrz80T5PA5P0pZTyC0keGIbh7x95SbMw5evlmmEYXpzk55K8ppTyhkf5PC1M1ZcTSV6W5MZhGJ6f5DDJHz6K55m9bYSGu/LwJHd1Vumsdp+7jzz2tKymhGqed86m6kvvJutLKeWJWU2//+kwDH+5wZq3YfLXyzAM/5PxtM0G6t2WqfrysiQ/W0o5TPKxJNeUUk5truzJTfZ6GYbhrnF9b1azUj+5saqnN+Xn0WeHYbhtvP/Pk7xwQzXPyxbOIR1P8u95+IUnbzyyz8VZNX39wpNXjI/dmIdfePKP5zumh2Wqvqwdu0hn52Enfr1ckNWFSm9rPcaZ9eWHklwybj8hq1D1G63H27ovR47v7r004evl0iQXjdsXJflIkje1Hu8M+nIsyWeSPH28/eYk72k93kl6uKUf1CuTfDbJHUn+bPxB/FKSd67t8/qsrmi/I8nvH/kBfnh87NNJrjvfMb0sE/ZlmeTLSe7PKhn/buuxtu5LVlfBP5DklrXlta3HOoO+XJ/k5iSnktye1ZTqsdZjbd2XI8+/SGehYcLXy09k9eF46/h6+QOvl/9/7KfH+04l+eskT2k91ikWfxobAKjif4QEAKoIDQBAFaEBAKgiNAAAVYQGAKCK0AAAVBEaAIAqQgMAUEVoAACqCA0AQBWhAQCoIjQAAFWEBgCgitAAAFQRGgCAKkIDAFBFaAAAqggNAEAVoQEAqCI0AABVhAYAoIrQAABUERoAgCpCAwBQ5burFDUbgrNLJQAAAABJRU5ErkJggg=="></div></div></div></div></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0407041F0BGAAAJ&amp;denomIds=4.7.4&amp;selectedTab=summary" target="_blank">Migril tablets : 3</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0601023AV&amp;denomIds=6.1.2&amp;selectedTab=summary">Saxagliptin/dapagliflozin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>546</td>
      <td>Other antidiabetic drugs</td>
      <td>8854</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>29.75</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_aXIpG0kKSkiSNMEo4ISsm1igd0w8pZ3"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_aXIpG0kKSkiSNMEo4ISsm1igd0w8pZ3" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0601023AVAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Saxagliptin 5mg / Dapagliflozin 10mg tablets : 43</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0601023AVBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Qtern 5mg/10mg tablets : 503</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0102000K0&amp;denomIds=1.2&amp;selectedTab=summary">Dicycloverine hydrochloride compound preparations</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>103</td>
      <td>Antispasmodic and other drugs altering gut motility</td>
      <td>1644</td>
      <td>0.06</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>7.49</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_m2m1KVbRaYlSxBKsVCkolypoq0MopUKt"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_m2m1KVbRaYlSxBKsVCkolypoq0MopUKt" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0102000K0BBAAAA&amp;denomIds=1.2&amp;selectedTab=summary" target="_blank">Kolanticon gel : 103</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0106050M0&amp;denomIds=1.6.5&amp;selectedTab=summary">Magnesium citrate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1</td>
      <td>Bowel cleansing preparations</td>
      <td>1</td>
      <td>1.00</td>
      <td>0.03</td>
      <td>0.13</td>
      <td>7.19</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_mIAZjQZJbBwjRsEgNC3FSqqLNDzYHGxi"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_mIAZjQZJbBwjRsEgNC3FSqqLNDzYHGxi" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0106050M0BBAAAA&amp;denomIds=1.6.5&amp;selectedTab=summary" target="_blank">Citramag effervescent powder sachets : 1</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0401010N0&amp;denomIds=4.1.1&amp;selectedTab=summary">Loprazolam mesilate</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_high_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>48</td>
      <td>Hypnotics</td>
      <td>2028</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>6.96</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_yilljprtQ9jCx7bIsVSxplGrIyUkfFp"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_yilljprtQ9jCx7bIsVSxplGrIyUkfFp" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0401010N0AAAAAA&amp;denomIds=4.1.1&amp;selectedTab=summary" target="_blank">Loprazolam 1mg tablets : 48</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <section aria-labelledby="lowerHeading">
      <div class="container">
        <h2 class="pb-3" id="lowerHeading">Prescribing where Dewsbury & Thornhill PCN is lower than most</h2>
      </div>
      <div class="container px-lg-4 mb-4">
        <div class="table-responsive">
          <table border="1" class="dataframe table table table-sm table-bordered" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Standard Deviation">std</abbr></th>
      <th><abbr data-bs-toggle="tooltip" data-bs-placement="top" title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=091101000&amp;denomIds=9.11.1&amp;selectedTab=summary">Other amino acidandnutritional agent preparations</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_0_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>0</td>
      <td>Amino acids and nutritional agents</td>
      <td>12</td>
      <td>0.00</td>
      <td>0.96</td>
      <td>0.17</td>
      <td>-5.60</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_BdJK9dBaglDaKVYjbm1iWY0WrVdqiXm"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_BdJK9dBaglDaKVYjbm1iWY0WrVdqiXm" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0&amp;denomIds=5.1.2&amp;selectedTab=summary">Cefalexin</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_1_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>144</td>
      <td>Cephalosporins</td>
      <td>186</td>
      <td>0.77</td>
      <td>0.96</td>
      <td>0.06</td>
      <td>-3.25</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_kgnGMlYKbDSaUiCGBOWWywhWGEAlUcNR"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_kgnGMlYKbDSaUiCGBOWWywhWGEAlUcNR" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0AAAAAA&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg capsules : 50</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0AAABAB&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg capsules : 38</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0AAACAC&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 125mg/5ml oral suspension : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0AAADAD&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg/5ml oral suspension : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0AAAGAG&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg tablets : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0AAAHAH&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg tablets : 19</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0AAANAN&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 125mg/5ml oral suspension sugar free : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0501021L0AAAPAP&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg/5ml oral suspension sugar free : 1</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0&amp;denomIds=6.3.2&amp;selectedTab=summary">Prednisolone</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_2_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>1660</td>
      <td>Use of corticosteroids</td>
      <td>2113</td>
      <td>0.79</td>
      <td>0.88</td>
      <td>0.03</td>
      <td>-3.01</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_aOpUbJIo4SDEg36YogkVEiKx2RtKYU"><img width="250" class="h-auto" src="data:image/png;base64,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"></button><div class="modal fade" id="plot_aOpUbJIo4SDEg36YogkVEiKx2RtKYU" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AAAAAA&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 1mg tablets : 120</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AAABAB&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 2.5mg tablets : 21</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AAACAC&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg tablets : 1284</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AAAFAF&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 2.5mg gastro-resistant tablets : 35</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AAAGAG&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg gastro-resistant tablets : 68</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AAATAT&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 1mg gastro-resistant tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AABHBH&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg soluble tablets : 124</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AABLBL&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 5mg/5ml oral solution unit dose : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0603020T0AABMBM&amp;denomIds=6.3.2&amp;selectedTab=summary" target="_blank">Prednisolone 10mg/ml oral solution sugar free : 1</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0802010G0&amp;denomIds=8.2.1&amp;selectedTab=summary">Azathioprine</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_3_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>221</td>
      <td>Antiproliferative immunosuppressants</td>
      <td>447</td>
      <td>0.49</td>
      <td>0.80</td>
      <td>0.10</td>
      <td>-3.00</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_ZsYZ66jooHgQJSKboiCIM8WRRQF11CGy"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAU40lEQVR4nO3deZQdZZ2H8edNQtjCDoKKUMgODiCoCI6IKCgUBwQUQRFUUA/qjI7blNt4ZsYZ66jooHgQJSKboiCIM8WRRQF11CGyiIbNgAWERZR9hyQ1f7zvtS8xnVRI962+3c/nnDr3dlU1+XVx+95vv/UuoWkaJEmSlmVa1wVIkqThYGiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaAEJYnRCatK3edTmSJE1EhgZJktTKjK4LkKQuZUW1CrAVsBmw9mLbWsAC4FHgsb7tXuCWtN1Vl3kz+MqlwQtN42s93ZJ4JH01i6Z5tMtyJI2PrKg2BvYAdgS2TdsLWbFW18eBPwI3A1cCVwBX1GV+74pVK008hgYwNEiTVFZULwBeBeyZts2XcNrtwPXAPGILwgN920PAdGC1vm114DnEsLF5elx3Cf/decQA8XPgorrMbxmbn0rqjqEBDA3SJJEVVQB2At6Qth0WO2UucBkwB7gOuKEu84fH4N9dG9gaeCmwK/Ay4i2PfrcAF6Xtp3WZP7ii/640aIYGMDRIQywrqmnA7sAbiUFh077DNwAXA5cDP6vL/M8DrGtdYnjYC9iHeEukZ0Gq6Tzg/LrM5w+qLmlFGBrA0CANoayotgGOAN4KZH2Hfs3Ih/GNHZS2RFlRbQi8lhgg9gU26Ds8B/ghcHZd5n/ooDypFUMDGBqkIZEV1frEoHAEsEvfoZ8D3wV+WJf5XV3UtjyyopoO7EZsGTmI2C+i5yriz/K9usxv76A8aVSGBjA0SBNYuv3wGuAY4gfsSunQ9cAZwHfqMq+7qW7FpX4Y2wOHAIcB2/Qd7oWhcwZ5a0UajaEBDA3SBJSGR74DeCcjtx8eIAaFU4CrJ9v8CClA7AAcTgwQvf4ZC4FLGGlNsROlOmFoAEODNEFkRbUSkBNbFfZlZP6ES4GTgfPqMn+8o/IGKgWI3YgB4lDiME+AJ4ELgNOBqi7zp7qpUFORoQEMDVLHsqLaEjgaeDuwYdp9N/BtYHZd5vO6qWxiyIpqBnGeicOJtzHWSofuI7Y+nAr8ZrK1vGjiMTSAoUHqQFZUqwIHE1sV9ky7FxH/ij4ZuKAu86e7qW7iyopqZWA/4Ehgf0aWA7geOA04wyGcGi+GBjA0SAOUFdUOwLuIIyDWTrtrYDZwSl3md3RU2tBJo0kOA44CXpJ2N8BPiAHi3LrMfT/TmDE0gKFBGmdpxsTDibcgekMlnyLOp3AycYbERR2VNylkRbUdsfXhbcDz0u5HgXOIty8u9xprRRkawNAgjYM0VHJP4uiHQ4BV0qHriEHh9LrM/9JNdZNXmgNiL2Lrw8HAqunQbcTOk6fVZX5TR+VpyBkawNAgjaGsqDYhfmC9g7jcNMDDxA573yKuAOkbzwBkRbUGcXrto4gLd/X8mtjJ9CyHb2p5GBrA0CCtoNQ570Biq8I+QEiHLicGhR94b71bWVFlxFsXRwJbpN2PE29fzCauzeEHgpbK0ACGBulZSp0ajyZ2auwtD30n8a/YU6b6UMmJKM3/sDsx4L2ZuNQ3wM3ESbNOdfSFRmNoAEODtBxSp8a3ED90ep0anwZ+RGxVuKgu8wUdlaflkBXVLOBNxOD3irR7EXAh8f/lj5w8Sv0MDWBokJahr1Pj0cTOdb1OjXOJTdtnuDbCcMuKamtiP5SjgI3S7r8Qp+3+Vl3mv+uqNk0chgYwNEijSJ0a3078MMnS7l6nxtnAHO+DTy5p9sl9iS1J/ZNHzSG2PpxVl/kDHZWnjhkawNAg9cmKaiZwAHGmxsU7Nc4mdmp8rKPyNEBZUW1I7Dx5NCOrbz5B7Dx5MnaenHIMDWBokPjr+g/HEFsWeosj2alRvc6TLye2PhwGzEqHrgNOJM654dDNKcDQAIYGTVlZUa0CHESc1vnVafdCoAK+CfzYTo3qlxXV6sRVN98D7Jp2PwqcCZxYl/k1XdWm8WdoAEODppysqLYlBoWjGBkqWRObnE+py/zOjkrTEMmKamfgWOCtjMw8+Sti68PZdZk/0VVtGh+GBjA0aEpIEzC9ifgX4t+n3QuAHxJbFS5xbQI9G2kY7pHAe4Gt0+57iR0nT6rL/OauatPYMjSAoUGTWlZUGxGDwrHAhmn3PGJQOLUu8z91VZsml9T3YU9ieHgDIyMv/gc4jrholh86Q8zQAIYGTUpZUe0CfIDYcW0l4qQ95wMnAJf65q3xlBXVc4kda98DPD/tvooYHs6uy/zprmrTs2doAEODJo30l95rgYK40iHAg8S+CifUZV53VJqmqDSE91Dgw8BOafftwPHAN+syf6ir2rT8DA1gaNDQS8shH0QMC72pnecBXyIOh3tktO+VBiEF2lcTw8N+affDwDeAr9RlfltXtak9QwMYGjS00ux9RwAfB7ZKu68GPgecW5f5wq5qk0aTFdV2wIeIE0fNJA7z/T5wXF3mV3ZZm5bO0ACGBg2d1LLwZuAzjISFy4hh4WL7K2gYpBkn30fsOLle2v1T4uv4J76OJx5DAxgaNDTSwlEHA/8KbJd2/wT4l7rMf9lZYdIKyIpqNeKcIR8GNk+7rwRK4DxbzCYOQwMYGjQUsqLak9hH4cVp1y+AT9dlfllXNUljKbWgHULsm9N7nd8EfJ64kuqTXdWmyNAAhgZNaFlRbQ58gdjREeAK4NN4G0KTVOo0uQ8xPOyZdt9JDM3fqMv84Y5Km/IMDWBo0ISUFdVawCeJcy3MBG4DPgZ837CgqSIrqpcD/0ycLArgfuJcI1+ty/zPnRU2RRkawNCgCSU10R4NfBbYgLgY0OeAL9Vl/niXtUldSSMuPkZc52IG8DhxVtPjHK45OIYGMDRowsiKai/gy8AOade3gU+6gJQUZUW1CXG45ruA1Yjrp3wH+Hxd5nO7rG0qMDSAoUGdy4pqS2K/hQPTrl8AH3TMurRkWVGtD/xD2tZJu88Hvgj8r7fwxoehAQwN6kxaHfBTwD8S14e4FfgocI5vetKyZUU1i9jq8GFG1ri4kjhN9ffqMn+qq9omI0MDGBo0cGkmx2OAfwfWJ77+/hP4cl3mT3RZmzSM0hoXbwE+COyYdt8NnAh8vS7ze7qqbTIxNIChQQOVFdVrgP8CXgQ0wCnAp+oyv6vTwqRJIA3X3IMYHg4EAvA0cC5xnYvL6jJf1F2Fw83QAIYGDUTqt/BF4IC062fAP9VlflV3VUmTV1ZULwTeD7wDWDvtnkccdfFtWx+Wn6EBDA0aV6nfwqeJHbZWAmrgI8QFpfwFlMZZVlSrEmeafDfwyrR7AXABcCbw3w5nbsfQAIYGjYvUb+FdxH4L6xFfY58FjrffgtSNrKi2Jf5eHsnIIlkPE29fnAn81LUuRmdoAEODxlS6p/o64q2I7Yn9FmYT14m4u8vaJEWp4+TriJNFHQiskg7dQxy6eR4xQLjeRR9DAxgaNGayotqVuDLfnmnX5cT5Fq7prChJS5UV1RrEtV2OAPYCpqdDDwEVMUBcWJf5Q91UOHEYGsDQoBWWFdU2xCGTvUWlrgc+AZxvvwVpeGRFtS6wP/F3+fWMtEAsAH5ODBEVcONU/N02NIChQc9a6p39CWLv7GnAfOAzwGl1mS/osjZJKyYrqtWJtzAOBPYlrgXTcwsjAeLyqdJPydAAhgYtt9SZ6uPEyWSmA/cRWxq+NlXePKSpJCuqacBLgTxtO/cdfgz4CSlE1GU+f/AVDoahAQwNai0rqh2Jy1W/kThpzL3EBaZOqMv8wS5rkzQ4WVE9F9iPGCD2Bmb1Hb6WkVaIX0+m0RiGBjA0aKnSUtX7EedZ2Dvt/hNxgamT6jJ/ZLTvlTT5ZUW1MnH+h16I2Krv8H3Aj4kB4sK6zO8dfIVjx9AAhgYtUVZU6wDvBN4HbJZ230oMC99yMhhJS5IV1RaM3MZ4FTAzHVoE/JqRVohrh60zpaEBDA36q3Tf8hXAUcDhwGrp0KXAV4gzx02apkZJ4yutwvlaYoDYD3he3+E/EieUOqMu8xs7KG+5GRrA0KDeXwZvS1uvVeEx4HRif4Xfd1WbpMkhTfy2EzFA7A/s2nd4DnAGcNZEXhPD0ACGhikqK6rNiGOx3wjs1nfoF8BpwNl1mT/QRW2SJr/0HvRW4h8rvX4QC4iTSZ1IXJFzQn1IGxrA0DBFpJS/AzEoHJSe99xCDApn1GV+cwflSZqi0nvTLsQZKY9gZE2M64GvE+d9mRB/wBgawNAwiWVFtT7wGmCftG3cd/gG4IfEVD9noiV6SVNPVlSrAG8CjmWkBfQx4FTgS3WZz+uqNjA0RIaGSSMrqrWA3YE9iMMjdybOpwBx4ag5pKBQl/kNnRQpSS1kRfViYnh4K7FT9iLgB3WZH9pVTYYGMDQMsTTByu7EMdJ7ADsSp3PuuQ24KG0/HfYx0pKmnjT8+1jgA8Bz6jIPy/iWcWNoAEPDkEjNdjsBL0/bbsAmi502H/gZcWGZS4GbvO0gaTJI74FH1mX+ja5qMDSAoWECyopqNWJHxV2Itxh2AbYHZvSd1gBziZOl/JwYFm41JEjS+Jix7FOk8ZUmP9mRZwaEbRlZ077nT8BvgF8Rg8Ic17eXpMExNGhg0rCiTYktCP3bVox0Vuy5E7gybVelx7tsRZCk7hgaNC6yoloDeBEjwWBH4O+ANZdw+u08MyBcVZf53QMqVZLUkqFBKySFg+0W27Yntigs7jHg/4jLxva239Vlfv9gqpUkrQhDg1rJimptYj+D7XlmQHjBEk5viDMs9oLBb9PjLXWZLxpIwZKkMWdo0F+lPgcbAVsC2zDSarAdz1yZrWcR8Afgur5tLnBjXeaPDaJmSdLgGBqmoDRRyJbEDohbLfZ81hK+ZSFwI88MBtcR50B4fBA1S5K6Z2iYpNI8B1vwt6FgK2D9Ub7tEeBq4Ka09YeDJ8e7ZknSxGZoGFJZUc0g9ifIgM36HnvPnz/Ktz5FXDmtFwz+0Pf8boc0SpJGY2iYgFLfgnWIH/wb9z1uwkgoeAF/O/lRzyLgjyw5GNxWl/nCcSxfkjRJGRoGKCuqacQw8Jy+bSP+Nhw8H1h1Gf+5O4nBoE6P/c/n12X+9Jj/AJKkKc3Q8Cyl1oBZwLppW6fv+bo8Mxj0tg1od83vI7YO3EFcgKn3OJ8YCm6ry/yJMfxxJElapim5YFVWVCsDa6RtzS3+cvsGl8w+9mKAl7331Pffs8Z6KxNnLlxjsce1eWZIWJ7QtQC4Z7HtT+mxPxjc6YgESdJENNCWhvTX+QxgJWBmehxtW/z4TGKT/bPdVmMkKMzsr+uONTf46/OHV179hBY/ypPAn4ktAvenx/7n9/PMUHAP8IATG0mShtm4hoasqB4kdtabnv6trm+HPEb8QH8IeLj3uNKiBY8ChwGs9vQT//b4zFXuW/yctN0P3GdLgCRpKhrX2xNZUT1AnBhoIbF5/um+7anFvl7S9tRizx9fkW3UUQMhrE6cowBgFk3z6NhcAUmSJo8p2aehjRDCXICmabbvupbJwms6tryeY89rOva8pmOr6+s5rYt/VJIkDR9DgyRJasXQIEmSWjE0SJKkVgwNkiSpFUODJElqxSGXkiSpFVsaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoQEIIewZQpgbQpgXQjg5hDB9Cec0IYRr+rb1uqh1GLS8nhuGEM4PIdwQQrgxhLB/F7UOi2Vd0xDCTou9Pu8LIXy5q3onupav0Y+kc64NIfw4hLBhF7UOi5bX9F/TOXNDCJ/pos5hEUI4PoQwP4SwYCnnLPOaj7UpHxpCCNOAk4E3NU2zBbAmcMQSTl3YNM1Ofdu9Ay10SCzH9TwVOLNpmm2A7YFfDa7K4dLmmjZNc03/6xO4Fzh78NVOfG2uZwhhS+BY4CVN0+wAXAN8ZNC1DouW13RfYG9gZ2AHYMcQwh6DrnWInA28ZLSDy/FeO6amfGgAXgrc2TTNdenr2cAhHdYz7JZ5PUMIWwMbNk3zfYCmaRYYwpZquV6jIYRdiRO3/XIQxQ2hNtczACsBq4YQAvEN+a7BlTh02lzTFwGXNk3zZNM0C4FLgDcPsMah0jTNL5qmuXspp3Ty2WVogI2B2/u+vg14wRLOmxZCmBNCuDKE8KHBlDaU2lzPbYB7QgjfDSFcHUI4LYSw7sAqHD5tX6M9RwBnjGtFw22Z17NpmpuAr6bz7iK2hh0/qAKHUJvX6NXAviGEtUIIqwAHLuEctbe87wtjwtAQ/6JoY9OmaV4K7AMcFEI4fBxrGmZtrucMYA/gP5qmeTFQA18Yz6KGXNvXKCGEGcChGBqWZpnXM/VZOhjYAng+cAvw0XGua5gt85o2TXMJcCZwGXAx8Dtg4fiWNam1fl8YS4aGmNT609kmwPzFT2qa5vb0eC/xhb/7QKobPm2u5+3AdU3T/D59fRawywBqG1atXqPJ64BbmqaZN+5VDa8213Mv4nW8KzWln42/80vT9n30uKZpXtw0zSuBO4AbBlTfZLQ87wtjxtAAvwE2DiFsl74+Gji3/4QQwjqpOY30eABw7UCrHB7LvJ7pnJkhhN4Lfm9g7oDqG0ZtrmnPEcDpA6lqeLW5nrcCu4YQ1kxf7w1ch0bT5n10Wghhg/T8ucC7gZMGWuXksjzvC2NmyoeG9FfEMcA5IYSbgUeA00MIB4QQTk6nbQPMCSH8FriS2Kw2u5OCJ7g217NpmkXAe4HzQwjXAq/HnumjavkaJYQwC9gX+F43lQ6Hlq/RK4gjfK4IIfwO2BQou6p5omv5Gp0OXB5CmAtcCHy0aZq6k4KHQAjhpBDCfGB6Gnr5tRDCS0IIF8Do13zc63JpbEmS1MaUb2mQJEntGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS1YmiQJEmtGBokSVIrhgZJktSKoUGSJLViaJAkSa0YGiRJUiuGBkmS1IqhQZIktWJokCRJrRgaJElSK4YGSZLUiqFBkiS18v+JQLevj/uwOAAAAABJRU5ErkJggg=="></button><div class="modal fade" id="plot_ZsYZ66jooHgQJSKboiCIM8WRRQF11CGy" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0802010G0AAADAD&amp;denomIds=8.2.1&amp;selectedTab=summary" target="_blank">Azathioprine 25mg tablets : 45</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0802010G0AAAEAE&amp;denomIds=8.2.1&amp;selectedTab=summary" target="_blank">Azathioprine 50mg tablets : 176</a></li></ul></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0&amp;denomIds=9.6.4&amp;selectedTab=summary">Colecalciferol</a><button class="btn btn-outline-primary btn-sm btn-xs ms-2 px-2" data-bs-target="#table_low_4_items" data-bs-toggle="collapse" type="button">&#9776;</button></th>
      <td>8281</td>
      <td>Vitamin D</td>
      <td>8918</td>
      <td>0.93</td>
      <td>0.97</td>
      <td>0.01</td>
      <td>-2.59</td>
      <td><button type="button" class="btn" data-bs-toggle="modal" data-bs-target="#plot_jjqoUyMjggiC4sxBwA1ERQsROIqKHgUU"><img width="250" class="h-auto" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAg0AAACWCAYAAABdJrs9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAXEQAAFxEByibzPwAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAThklEQVR4nO3debQcZZ2H8ecNYYkJBARZlKXGERfC4gKiiMgiayEuIM4IDMsIjLgBCpY4jjqoUyMjggiC4sxBwA1ERQsROIqKHgUUCYILEgsCAgKiQCRAoOaPt3LSNyb3VtJLdd/7fM6pU93V1XV/VenU/d6333orVFWFJEnSRKa1XYAkSRoNhgZJktSIoUGSJDViaJAkSY0YGiRJUiOGBkmS1IihQZIkNWJokCRJjRgaJElSI4YGSZLUiKFBkiQ1YmiQJEmNGBokSVIjhgZJktSIoUGSJDViaJAkSY0YGiRJUiOGBkmS1IihQZIkNWJokCRJjRgaJElSI4YGSZLUiKFB0lghzCSEqp5mtl2OpOFhaJAkSY1Mb7sASVLvJFnxbGBb4MXABsBjwALgx8AVZZ4+0mJ5GnGhqqq2a5A0TOJXEot/scyiqha0WY4mlmTFBsDB9fTCcVZ9DPgmcGKZp7cPojZNLoYGSWMZGkZGkhX/CLwHOBxYvV58M/B94BfAHcBqwLrAXkAKrA38DfggcFqZp4sGXLZGmKFB0liGhqGXZMWzgA8BRxD7pj0CnAucB9xY5ukyT+xJVswATgLeC6wKfAs4sMzThQMoW5OAoUHSWIaGoZVkxdOIv/TfDawBPAicCpxZ5umDK7CdFwCXAM8HrgReX+ap/86akKFB0liGhqGUZMW+wBlAAjwKnAZ8vMzTv6zk9tYnBoatgR8Ce5R5+lhvqtVkZWiQNJahYagkWbEpcDrwunrR14Fjyzy9owfbfjoxOLwYOKvM07d1u01NboYGSWMZGoZCkhXTgHcCHwFmAiXwjjJPv93jn7MxsdPkM4BDyjy9oJfb1+Ti4E6SNGTqX+RXAp8kXv3wMWBOrwMDQJmndwL/BDwFfDbJiq16/TM0edjSIGksWxpalWRFCpwPrAP8CjiozNO5A/i57wVy4HrgZWWePtnvn6nR44iQkjQE6q8jTgL+EwjEfgzZAC+HPIXYb+JlwNvrny+NYUuDpLFsaRi4JCvWILYuHEAc8vmwMk8vbqGOrYj9GxYCW5R5On/QNWi42adBklqUZMVawHeIgWEe8auBgQcGgDJPbyK2OMwCPt1GDRpuhgZJakmSFesBVwM7AzcAO5R5+qs2awJOJoaX/ZKs2K3lWjRkDA2S1IIkK9YGrgBeRB0cyjy9t9WigDJPHwWy+ul/130tJMDQIEkDl2TFLOAylgSGfco8fajVosa6GLgOeAnwxpZr0RAxNEjSACVZsSrxvg8vB34K7Ff/dT806htenVg//ViSFau1WY+Gh6FBkgYkyYpAvH/E7sBNxBaGh9utatnKPL2a2EHz2cCR7VajYWFokKTBeSdwNHAvsO+K3JmyJe+r55mtDQJDgyQNRJIVuxNvY72Q+JVE1zec6rcyT28ELgU2Bg5tuRwNAUODJPVZkhXPBC4knnMPL/P02pZLWhEfqefvq/tjaAozNEhSHyVZMR34EvEukmeWefrllktaIWWeXgd8F/gH4M0tl6OWGRokqb8+DOxEHJ753S3XsrJOrucnJVmxSquVqFWGBknqkyQr9iTehOoh4MAyTx9ruaSVUubpj4EfAM8F9m25HLXI0CBJfZBkxcbABfXTI8o8va3NenrgE/X8+FarUKsMDZLUYx39GNYDzijz9Gstl9QLBXArsFOSFdu2XYzaYWiQpN47GdgRuB44oeVaeqLM06eAT9ZPj2uzFrXH0CBJPZRkxT7EGz79FXjTqPZjWI7zgD8DByZZsUnbxWjwDA2S1CP1L9Lz66eHl3k6r816eq3M078BnwGmA+9ouRy1wNAgST1QD3z0ZeDpwOllnn695ZL65UzgCeCoJCvWbLsYDZahQZJ646PADsRbSp84wbojq8zTu4EvArOBw1suRwNmaJCkLiVZsS+xw+NfiOMxPN5ySf22uEPksQ72NLUYGiSpC0lWJMAX6qeHlXlatlfNYNQ3srqKOLT0a1suRwNkaJCklZRkxdrE8QvWAU4t8/SbLZc0SKfW81EdGlsrwdAgSSuh7vh4MbAF8B3gve1WNHDfBX4N7JBkxUvbLkaDYWiQpBWUZMU04LPAbsBc4ngMi9qtarDqwZ5Or58e22YtGhxDgyStgDownA0cBvwR2LfM04dbLao95xMHe3pjfa8NTXKGBklqqA4MZwFHAncDu5R5Or/dqtpTD/Z0NnGwp7e1XI4GwNAgSQ0kWfE04CvA0cA9xMDwu3arGgpnAYuAo5OsmNl2MeovQ4MkTSDJio2Aq4EDgHnAzmWe/rbVooZEmad3EcPUOsAhLZejPjM0SNI4kqzYE7gB2A74EbC9geHvnFbPj62/wtEk5T+uJC1DkhUzkqw4Fbgc2IB4tcTuZZ7e325lw6fM0+uBa4DnAXu1XI76aHrbBUjSsEmy4lXA54DNgQeBI8s8/Vq7VQ2904AdiZdfXtZyLeoTWxokqZZkxewkK84m9l/YnDho0zYGhka+AZTA7klWbNlyLeoTQ4MkAUlWpMDNxKsj7gcOAtKpfEnliijz9EngU/XTd7VZi/onVFXVdg2ShkkIM4FH6mezqKoFbZbTb0lWrEdsWj+oXvRF4NgyT+9rr6rRlGTFbGA+sBqwWZmn97ZcknrMlgZJU1aSFfsDtxADw13AfmWeHmRgWDllnv6V2BdkdeCdLZejPrClQdJYU6ClIcmKGcTWhaPqRZ8FTqx/6akL9XDS84C/AZuWefpQyyWph2xpkDSlJFmxOXAtMTD8CdizzNOjDQy9UebpncAFwGxi/xBNIoYGSVNGkhW7Aj8DtgSuIl4ZcUW7VU1KpwAVcFySFau3XYx6x9AgaUpIsuKtwBXE4Y5PAfYq8/SedquanMo8/TXwTWAj4NCWy1EP2adB0liTrE9DkhWrEvsvHAM8DhxV5ul57VY1+SVZ8VJiq87twHPLPH285ZLUA7Y0SJq0kqxYhzhA0zHE/gu7GBgGo8zTa4EC2Aw4rN1q1CuGBkmTUpIVzyP+pbsbMBd4aZmnP2m3qinnQ/X83+3bMDkYGiRNOklW7EEMDJsThzd+RZmnt7db1dRT38jqUmAT4IiWy1EPGBokTRpJVoQkK95OvGHSbOC/gP3LPH1k/Heqjz5Uz9+fZMXT2ixE3TM0SJoUkqxYDTgLOANYBBxS5ulJZZ4+1W5lU1uZpzcAFwPPAo5vuRx1ydAgaeTVAzb9BPg34F5g5zJPL2i3KnXIiFeuZElWbNR2MVp5hgZJIyvJimlJVhwJ3AC8BLgG2K7M05+2W5k6lXl6G/EOmDOBk1suR10wNEgaSUlWbA38iHjfiBnE78538VbWQ+ujxFuOH5FkxQvbLkYrx8GdJI015IM7JVnxfOD9wJuJf/j8AnhrPS6AhliSFccAZwLXAS8v8/TJlkvSCpredgGSNJEkK6YDewJvAV4LBOABYuvCZ/zlMzLOAf4F2B54F3Bqu+VoRdnSIGmsIWlpSLJiLeDVwN5ASryPAcSRHU8BzvZSytGTZMUcYh+URcBWdX8HjQhDg6SxWgoNSVYEYA6wDzEo7MiS1tCngCuBzwOXlnn62CBqUn8kWfEfwIeBq4FX21I0Ovx6QlJr6rEVdgFeB+wLbNzx8n3A5cR7R1xR5ukDg69QfZID+wM7Ax9gyQBQGnK2NEgaq88tDUlWrElsTXhdPV+rfqkCriWO5vgd4OcOzDR51fcGuQ6YBexT5unlLZekBgwNksbqQ2hIsmIa8a/Kw4h/YS4eTngh8F3i/SGKMk/v6/ZnaXQkWXEAcBHwZ+AlZZ6W7VakiRgaJI3Vw9CQZMVzgEOJPeY3rRcvAC6ppyvLPB2qSzo1WElWfII4vPStwCvLPL235ZI0DkODpLG6DA1JVqwLvIEYFl7R8dL3gfOAr3nVgxarL6f9KvB64CbiEOB/brcqLY+hQdJYKxEa6qDweuCNwK4s6WQ9jxgUvmDTs5YnyYrVgW8BuwPXA68p8/SedqvSshgaJI3VIDQkWbEKsA2wG7AH8QqIVeqX7yN+9XAhcE2Zp55kNKEkK2YSO8HuBMwnBocb261KSzM0SBqrIzRctNWrn37CPsfOIvZHeD6wBbAt8GJir/fF/kQMChcBPyzzdNFAa9akkGTFGsDngIOJfV/eDpxn8BwehgZpiqnHRtignjbseLwBsOGsxxZs9KvT3vRKgBccdzGPrrbGsjbzCPFyue/V07UGBfVCPchXRrzBVQCuAo4u83Req4UJMDRIk0p9wl2X2DKweNpsqecbjreNGY8v5NefPACAOcdd9IcFq824B7gL+E093QD81lH81E9JVrycOALoC4AngC8AeZmnv2+1sCnO0CCNiDoQrEW8B8MzgU1YdjCYMc5mFhEDwB+Be+vpns7H299x00Nf+dL7bqrXH7q7XGrqqDtIngC8B5hNHE78e8CXgG94lcXgGRo06dQDCU0HVl3OfLzXmqyz9OPQ8eOrpebLWzatft+0ZTyeSQwHa9bz2cSvDjZiyaBIy/MgcAdwez1ferpnwhaCIblhlbRYkhWzgWOAd7DkxmUVMBf4EfBL4BbgNuABW8H6x9CgCSVZsR5wCMv+BTetwfLO11ahN7+sx1tnWn+OROseJLYQ3F1PSweC+WWePtz1TzE0aEjVV+3sBPwz8aqdzZax2lPA/SxpPXuQOPLoo/W0EHi8Xq+q58t7/ESZp5/q3x6NHkODJpRkxZbEQVeGSUX8nnNRx3zRMpb1e50niScXWNLi0NnysLxlT/H3J6jF8wXAQ8DDHfM/lXm6cIWP0sowNGhEJFmxKbAD8e6oc4ghYgNgfeIfEt1aWObpeF/3TTlTJjSEEG4GqKpqTtu1tMVj4DGY6vsPHoOpvv/gMejGZG3GlSRJPWZokCRJjRgaJElSI4YGSZLUiKFBkiQ1YmiQJEmNTJlLLiVJUndsaZAkSY0YGiRJUiOGBkmS1IihQZIkNWJokCRJjRgaJElSIyMbGkIIO4cQbg4h/D6EcG4IYZVlrPOeep25IYTLQwgb1MsPCyE8EEL4ZT2d2fGeLUMIPw8h3BpC+EYIYdYg92tFdHkM/qNj/28MIVQhhG3q166u93/x63sOet+aangMPlyvc3MI4YMdy6eHEP6vfu/NIYRXrsh2h0GX+398x2fjxyGEF3a8NlU+AyN/Luhy/yfLeeD0EMKdIYRF46yzzOM0Gc4DA1VV1chNxLDze2CL+vlXgUOXWmdz4DZgRv08B06pHx8GnLucbV8D7FE//jjwwbb3tx/HYKn1dgR+2/H8amDHtvexR8dgb+AnwOrAKsAlwE71a28Bvlg/3hr4HRCabHcYph7s/67AzI71bpiCn4GRPhd0u/9LrTeS54GO2jcEFq3ocRr188Cgp1FtadgO+GNVVbfUzz8P7L/UOgFYFZgRQgjAWsDd4220/it806qqrhhnu8Oil8fgIOCCfhXaR02OwZbA96uqeqyqqieBq4A31a/tD5wLUFXVXOAB4EUNtzsMutr/qqq+V1XVgnq9nwGbDqDmXuv2M7BMI3Qu6OX+j+p5gKqqrqmq6p5xVhnvOI36eWCgRjU0bAzM73h+B7BJ5wpVVf0OOKNe725gDnB6xyqvqZvjrgghbNd0u0OkF8eAEMKqwAH8/cninPr4fDqEsGaPa++VJv9eNwB7hxBmhxDWAF7bsc7y3j8qn4Nu97/T0cBlSy2bCp8BGO1zQU8+AyN+HmhivOM06ueBgRrV0BAmXCGEdYE3AM8BngXMA06oX/42kFRVtQ3wUeDr9feVE253iHR7DBbbh9gk+YeOZQdXVTUH2BZ4EvifnlTcexMeg6qqrgIuJDa1XgncRNyn8d4/Kp+Dbvc/biSEvYHDgeM7Fk+Vz8Conwt68hlgtM8DTYx3nEb9PDBQoxoa5jM28W0K3LnUOrsC86qqurtukrsI2AGgqqr7q6p6tH78g/q9z6vnE213WHR1DDocDJzfuaCqqjvr+RPAZ5bxnmHR5BhQVdUnqqp6UVVVrwTuAn4zwfsbbXcIdLv/hBB2AM4E0qqq7ut4z5T4DEyCc0HXn4HaKJ8HmhjvOI36eWCgRjU0XA9sHELYon7+r8TOPZ1uB7YPIaxVP98duAUghPDMxSuFEOYACfGX6z3A/BDCHuNsd1h0dQwAQgiz62Vf7Vg2PYSwfsc2DgTm9rj2XpnwGIQQpoUQnlE/3gg4CjinfvkSYicoQghbA88AftFku0Oiq/2v9/lC4A1VVd3a8Z4p8xmYBOeCbv8PTIbzQBPjHadRPw8MVts9MVd2Iv4VfQvx6oD/BaYD+9HRExr4ADFR30T8x167Xv4x4Gbgl8B1wF4d79ma+B3grcClwJpt72s/jkH92hHAJUttcybxP8vc+j0XAeu3va8rewyIHUFvqf+95wL7drx3VeA8Yg/pW4BXjbfdtve1D/t/JXBf/f9g8bTaFPsMjPy5oJv9r1+fDOeBc4itAFU9P5P4tcpl4x2njuMz0ueBQU7eGluSJDUyql9PSJKkATM0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJasTQIEmSGjE0SJKkRgwNkiSpEUODJElqxNAgSZIaMTRIkqRGDA2SJKkRQ4MkSWrE0CBJkhoxNEiSpEYMDZIkqRFDgyRJauT/AcdPS1xHhDuoAAAAAElFTkSuQmCC"></button><div class="modal fade" id="plot_jjqoUyMjggiC4sxBwA1ERQsROIqKHgUU" tabindex="-1" aria-hidden="true"><div class="modal-dialog modal-xl"><div class="modal-content"><div class="modal-header"><button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button></div><div class="modal-body"><img class="w-100 h-auto" src="data:image/png;base64,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"></div></div></div></div></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><ul class="my-0 ps-4 py-2"><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AAANAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit capsules : 285</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABGBG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit tablets : 283</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABHBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit capsules : 81</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABIBI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit capsules : 6</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABSBS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABTBT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000units/ml oral drops sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABUBU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 1.25g chew tab : 39</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABWBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g chew tab : 346</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABXBX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 440unit/Calcium carb 1.25g efferv gran sach : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AABYBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g chewable tab : 412</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AACBCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.5g efferv tab : 135</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AACCCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit / Calcium carbonate 1.25g tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AACDCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 200unit / Calcium carbonate 750mg tablets : 396</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AACQCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 10,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AACRCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit tablets : 18</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AACSCS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit tablets : 302</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AACYCY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADBDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADFDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 3,200unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADHDH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000units/1ml soln ud amp sugar free : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADKDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADLDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 800unit / Calcium carbonate 2.5g chewable tab : 29</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADQDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,400units/ml oral drops sugar free : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADRDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 20,000unit capsules : 602</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADTDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 2,740units/ml oral drops sugar free : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AADUDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000units/1ml soln ud amp sugar free : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AAEBEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 1,000unit / Calcium carbonate 2.5g chew tab : 9</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AAECEC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 4,000unit capsules : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AAEKEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 25,000unit capsules : 23</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AAELEL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400unit tablets : 60</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AAEQEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 50,000unit capsules : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0AAETET&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Colecalciferol 400units/ml oral drops sugar free : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BIABBH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 1,000unit capsules : 7</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BIADDV&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 10,000unit capsules : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BIAICU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 2,000units/ml liquid : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BKAABS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 tablets : 121</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BKABDI&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Accrete D3 One a Day 1000mg/880unit chewable tablets : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BMAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Valupak Vitamin D3 1,000unit tablets : 87</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BNAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 chewable tablets tutti frutti : 1505</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BNABBY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Lemon chewable tablets : 69</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BNACCB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 Dissolve 1500mg/400unit effervescent tablets : 53</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BNADCD&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Adcal-D3 750mg/200unit caplets : 1322</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BPAABX&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Cacit D3 effervescent granules sachets : 11</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BQAABW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calceos 500mg/400unit chewable tablets : 479</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BRAABU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 chewable tablets : 62</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BRABBW&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 Forte chewable tablets : 227</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BRACCC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 500mg/400unit caplets : 8</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BRADDL&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calcichew D3 1000mg/800unit Once Daily chewable tablets : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BSAABZ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calfovit D3 oral powder sachets : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BWAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 1,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BWABCQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 10,000unit tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BWACCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 20,000unit tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BWAEDB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 2,000unit tablets : 3</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BWAGAC&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">SunVit-D3 3,000unit tablets : 2</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BXAAAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 800unit capsules : 116</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BXABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 3,200unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BXACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 20,000unit capsules : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0BXADDT&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Fultium-D3 2,740units/ml oral drops : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0CCAADS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Pro D3 forte 3,000units/ml liquid : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0CGAADR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 20,000unit capsules : 465</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0CGABDF&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Hux D3 3,200unit capsules : 50</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0CHAGCR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Aciferol D3 20,000unit tablets : 1</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0CJAACS&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Desunin 800unit tablets : 122</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0CWAABY&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Evacal D3 1500mg/400unit chewable tablets : 5</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DFAADH&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000units/1ml oral solution : 80</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DFABDQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 2,400units/ml oral drops : 20</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DFACDU&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000units/1ml oral solution : 45</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DFADAN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 800unit capsules : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DFAFEQ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 50,000unit capsules : 15</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DFAGEK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 25,000unit capsules : 10</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DFAHEJ&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">InVita D3 5,600unit capsules : 4</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DHAABG&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 1,000unit tablets : 14</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DHABDK&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Stexerol-D3 25,000unit tablets : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DIAADN&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 10,000units/ml oral drops : 13</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DIABDP&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Thorens 25,000units/2.5ml oral solution : 135</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DMAAEB&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Calci-D 1000mg/1,000unit chewable tablets : 17</a></li><li><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U66858&amp;numIds=0906040G0DNACDR&amp;denomIds=9.6.4&amp;selectedTab=summary" target="_blank">Strivit-D3 20,000unit capsules : 1</a></li></ul></td></tr></tbody></table>
        </div>
      </div>
    </section>

    <script
      crossorigin="anonymous"
      integrity="sha512-pax4MlgXjHEPfCwcJLQhigY7+N8rt6bVvWLFyUMuxShv170X53TRzGPmPkZmGBhk+jikR8WBM4yl7A9WMHHqvg=="
      referrerpolicy="no-referrer"
      src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap/5.1.3/js/bootstrap.bundle.min.js"
    ></script>
    <script>
      var tooltipTriggerList = [].slice.call(
        document.querySelectorAll('[data-bs-toggle="tooltip"]')
      );
      var tooltipList = tooltipTriggerList.map(function (tooltipTriggerEl) {
        return new bootstrap.Tooltip(tooltipTriggerEl);
      });
    </script>
</body>

</html>